Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- For ...

A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart - transcatheter aortic valve replacement (TAVR) - and surgical aortic valve replacement ...

For the rising number of patients needing aortic reintervention, transcatheter aortic valve replacement (TAVR) explantation carried the highest mortality risk, two registry analyses affirmed. In ...

Not only is TAVI bringing aortic valve replacement (AVR) to a wider range of US patients with severe symptomatic aortic stenosis, but it has also yielded better outcomes over time, according to an ...

Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated with substantial decreased rates of death or stroke at one year in low-risk patients, compared ...

ORLANDO – November 5, 2021 – An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in ...

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...

Better to intervene early with a new valve in patients with severe aortic stenosis (AS) who are asymptomatic, even during exercise, than to wait for the disease to progress and symptoms to emerge ...

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global transcatheter aortic valve replacement market to grow at a CAGR of approximately 18% during the period 2018-2022, according to their ...

Transcatheter aortic valve replacement (TAVR) has surpassed surgical aortic valve replacement (SAVR) as the procedure of choice for aortic valve replacement in the United States, a new report of ...